IBRO Neuroscience Reports (Oct 2023)

EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS

  • Mari Paz Serrano-Regal,
  • Leticia Calahorra,
  • Inmaculada Alonso-García,
  • Ursula Boschert,
  • Philipp Haselmayer,
  • María Cristina Ortega,
  • Isabel Machin-Diaz,
  • Celia Camacho-Toledano,
  • Jennifer García-Arocha,
  • Diego Clemente

Journal volume & issue
Vol. 15
pp. S272 – S273

Abstract

Read online

No abstracts available.